Dr. Joseph Holson gave a presentation on this subject at the winter meeting of The Toxicology Forum in Washington, DC in February, 1999. The meeting was well attended by FDA and industry representatives. The instrument will increase WIL's abilities to meet our clients' growing needs in the areas of bioanalytical chemistry and compound identification, particularly in support of pharmacokinetic and metabolism studies. WIL has a history of successfully developing and validating bioanalytical methods using LC, GC, and GC-MS, and this powerful new tool will augment our endeavors in this area. WIL's analytical services continue to grow, both in support of studies conducted at WIL and in contracted analytical work to support projects conducted at other laboratories.
Further information is available on specific assays.
We began our effort toward Y2K issues in 1996 and can provide clients with a Year 2000 readiness disclosure statement upon request. Over the past 15 months, WIL has made significant progress toward a total technology upgrade. This hardware upgrade will allow WIL to continue to provide quality reporting and data collection well into the next millennium. Electronic Reporting Capabilities WIL is one of the first contract laboratories to have an automated data collection system, and at present, having one of the most comprehensively automated laboratories in the world. Because the PDF is independent of platform, it is an ideal foundation for long-term information distribution, archiving and retrieval strategy and is becoming a de facto standard for publishing electronic documents both in corporate intranets and for FDA submissions.